This cohort study evaluates the author and publication characteristics of retracted randomized clinical trials.

Background Reproducing published findings from clinical trials is a critical component of scientific transparency, yet it remains a challenging and under-practiced task. Despite increasing emphasis on...

While data sharing holds great potential to maximize the value of research and reduce waste, these benefits can only be fully realized if shared data are also effectively reused. Yet, data reuse remai...

Attendance at the EMA Biostatistics Special Interest Area Journal Club 2026.01.21 Prof. Dr. Martin Posch (MUW) will present on February 18, 2026 at th…

Objectives To provide information on the frequency and reasons for outcome reporting bias in clinical trials. Design Trial protocols were compared with subsequent publication(s) to identify any discr...

The use of individual participant data instead of aggregate data in meta-analyses has many potential advantages, both statistically and clinically. Richard D Riley and colleagues describe the rational...

Participants in clinical trials should be pro-actively offered the results of trials in which they have participated. This should be done in a way that is accessible and understandable for all partici...

The combination of AI and national health databases offers opportunities, but may also be exploited by unethical agents. This study shows that there has been an explosion of formulaic research article...